IBM

How To Bank 8.8% A Year On IBM Stock Before Buying A Single Share

Get paid a healthy income upfront for simply agreeing to buy this tech stalwart at a deep discount, an income you keep even if the stock never drops to your price.

3 Unpopular Stocks Walking a Fine Line

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other business lines such as M&A advisory.

NVIDIA & 4 Stocks Beyond Pure Plays to Gain From Quantum Boom in 2026

NVIDIA and four tech giants offer quantum exposure through cloud, software and infrastructure, helping investors tap the boom beyond pure plays.

Discover which dow jones stocks are making waves on Wednesday.

Get insights into the dow jones index performance on Wednesday. Explore the top gainers and losers within the dow jones index in today's session.

Is Oracle Stock A Hedge Or A Downside Trap?

The tech giant's sudden swings can be disorienting, but its true significance for your portfolio lies in its distinct, high-octane behavior.

Cisco vs. IBM: A Dividend Showdown Between 2 Tech Giants

Cisco and IBM both cut dividend checks to shareholders this month, but one company earns a grade that might surprise income investors who judge payouts by yield alone.

Fiserv CEO Focused on Simplifying Operations, Reducing Silos, UBS Says

Fiserv (FISV) Chief Executive Takis Georgakopoulos is focused on "simplifying" the company's operati

Transgene and Nec Report 100% Three-Year Disease-Free Survival with TG4050 and Publish Phase 1 Results in Nature Communications

TG4050 as a single agent has the potential to prevent recurrence in head and neck cancer Peer-reviewed publication in Nature Communications highlights the Phase 1 clinical and translational findings, including durable neoantigen-specific T cell responses Together, the long-term clinical and translational data further strengthen confidence in Transgene’s individualized neoantigen therapeutic vaccine approach and myvac® platform Strasbourg, France & Tokyo, Japan, September 2, 2026, 6:00 p.m. CET –